Table III.7: Reported Provisions Related to Reporting of Compounded Drug Products, by Reporting State, as of January 1, 2016
State Pharmacists report adverse drug events to the state pharmacy board or other entity Adverse drug events are reported to the state pharmacy board or other state entity, or FDA's MedWatch programa Compounded drug recalls are made public by the state pharmacy board or other state entity Specific corrective actions for quality control deviations by pharmacists or pharmacies are made public by the state pharmacy board or other state entity Complaints filed by another state are reported to the state pharmacy board or other state entity Nonresident states report to resident state board of pharmacy on any actions taken against resident entities
Alabama No No No No No No
Arizona No No No Yes Yes No
Arkansas No No No No No No
California Yes Yes Yes Yes Yes Don't know
Colorado Yes No Yes Yes Yes Yes
Connecticut No Yes Yes Yes No Yes
Delaware Yes Yes Yes Yes Yes Yes
District of Columbia Yes Yes No No No Yes
Florida No No No Yes No No
Georgia Yes Yes No No Yes Yes
Guam Don't know No No No No No
Hawaii No No No Yes Yes Yes
Idaho No Yes Don't know Don't know Yes Don't know
Illinois No No No No No No
Iowa No Don't know No No Don't know Yes
Kansas No No No Yes Yes Yes
Kentucky No No No Yes No Yes
Louisiana No No No No Yes Yes
Maine - - - - - -
Maryland - - - - - -
Massachusetts Yes Yes Yes Yes Yes Don't know
Michigan Yes Yes Don't know Don't know Don't know Don't know
Minnesota No No No No Yes Yes
Mississippi No No Don't know No Yes Yes
Missouri No No No No Yes Don't know
Montana No No No Yes Yes No
Nebraska No No No Yes No Yes
Nevada No No Yes No Yes Don't know
New Hampshire Yes Yes Yes Yes Yes Yes
New Jersey No No Yes Yes Yes Yes
New Mexico No No No No No No
New York Yes No No No Yes Yes
North Carolina Yes Yes Yes Yes Yes Yes
North Dakota No No No No Yes Yes
Ohio Yes Yes Yes No No No
Oklahoma No No No Yes Yes Yes
Oregon Don't know Don't know No No Yes Yes
Pennsylvania No No No Don't know Yes Yes
Rhode Island No Yes Yes No Yes Yes
South Carolina Yes Yes No Yes Yes Yes
South Dakota No No Yes Yes Yes Yes
Tennessee No Yes Yes No No Yes
Texas Yes Yes Yes No Yes Don't know
Utah No Yes No - - -
Vermont No No No No Yes Yes
Virginia Yes Yes Yes No Yes -
Washington No No No No Yes Yes
West Virginia - - - - - -
Wisconsin Don't know Don't know No Yes Yes Yes
Wyoming No Yes No Yes Yes Don't know

Source: GAO survey of state pharmacy regulatory bodies, survey question 15. | GAO-17-363SP
Notes: GAO surveyed the state pharmacy regulatory bodies in the 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands, and all but 4 completed the survey.
aMedWatch is the Food and Drug Administration’s (FDA) adverse event reporting system.